The relationship between plasma homocysteine and amino acid concentrations in patients with end-stage renal disease

Journal of Renal Nutrition

Volumn 8, Issue 1, 1998, Pages 34-39

  Hong, Sae Yong ^a   Yang, Dong Ho ^a   Chang, Sung Keun ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010171     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-2276(98)90035-8     Document Type: Article

References (34)

1. Hak, LJ, Nutrition in patients with renal failure. Torosian, MH, (eds.) Nutrition for the Hospitalized Patient: Basic Science and Principles of Practice, 1995, Marcel Dekker Inc, New York, NY, 493–503.
2. Canepa, A, Filho, JCD, Forsberg, AM, et al. Nutritional status and muscle amino acids in children with end stage renal failure. Kidney Int 41 (1992), 1016–1022.
3. Ikizler, TA, Flakoll, PJ, Parker, RA, et al. Amino acid and albumin losses during hemodialysis. Kidney Int 46 (1994), 830–837.
4. Mitch, WE, Walser, M, Nutritional therapy of the uremic patient. Brenner, BM, Rector, FC, (eds.) The Kidney, ed 4, 1991, Harcourt Brace Jovanovich, Philadelphia, PA, 2186–2213.
5. May, RC, Kelly, RA, Mitch, WE, Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: The influence of metabolic acidosis. J Clin Invest 79 (1987), 1099–1103.
6. Papadoyannakis, NJ, Stefanides, CJ, McGeown, M, The effect of the correction of metabolic acidosis on nitrogen and protein balance of patients with chronic renal failure. Am J Clin Nutr 40 (1984), 623–627.
7. Bergstrom, J, Furst, P, Noree, LO, et al. Intracellular free amino acids in muscle tissue of patients with chronic uremia: Effect of peritoneal dialysis and infusion of essential amino acids. Clin Sci Mol Med 54 (1978), 51–60.
8. Castellino, P, Luzi, L, Simonson, DC, et al. Effect of insulin and plasma amino acid concentrations on leucine metabolism in man: The role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 80 (1987), 1784–1793.
9. Castellino, P, Solini, A, Luzi, L, et al. Glucose and amino acid metabolism in chronic renal failure: Effect of insulin and amino acids. Am J Physiol 262 (1992), F168–F176.
10. Ueland, PM, Refsum, H, Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 114 (1989), 473–501.
11. Wilcken, DEL, Wilcken, B, The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57 (1976), 1079–1082.
12. Robinson, K, Mayer, EL, Miller, DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 92 (1995), 2825–2830.
13. Boers, GH, Smals, AG, Trijbels, FJ, et al. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest 72 (1983), 1971–1976.
14. Tsai, C, Perrella, MA, Yoshizumi, M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis., ed 29 Proc Natl Acad Sci USA, 91, 1994, 6369–6373.
15. Harpel, PC, Chang, VT, Bort, W, Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherosclerosis, and sulfhydryl coumpound metabolism., ed 29 Proc Natl Acad Sci USA, 89, 1992, 10193–10197.
16. Hajjar, KA, Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91 (1993), 2873–2879.
17. Parfrey, PS, Cardiac and cerebrovascular disease in chronic uremia. Am J Kid Dis 21 (1993), 77–80.
18. Chauveau, P, Chadefaux, B, Coude, M, et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43:suppl 41 (1993), S72–F77.
19. Perna, AF, Ingrosso, D, Galletti, P, et al. Membrane protein damage and methylation reaction in chronic renal failure. Kidney Int 50 (1996), 358–366.
20. Wilcken, DEL, Dudman, NPB, Tyrrell, PA, et al. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metabolism 37 (1988), 697–701.
21. Ellis, JM, McCully, KS, Prevention of myocardial infarction by vitamin B6. Res Commun Mol Pathol Pharmacol 89 (1995), 208–220.
22. Verhoef, P, Stamofer, MJ, Buring, JE, et al. Homocysteine metabolism and risk of myocardial infarction: Relation with vitamin B6, B12, and folate. Am J Epidemiol 143 (1996), 845–859.
23. Mayer, EL, Jacobsen, DW, Robinson, K, Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27 (1996), 517–527.
24. Robinson, K, Mayer, EL, Miller, DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 92 (1995), 2825–2830.
25. Arnadottir, M, Brattstrom, L, Simonsen, O, et al. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrology 40 (1993), 236–240.
26. Bostom, AG, Shemin, D, Lapane, KL, et al. High dose B-bitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49 (1996), 147–152.
27. Refsum, H, Helland, S, Ueland, PM, Radioenzymic determination of homocysteine in plasma and urine. Clin Chem 31 (1985), 624–628.
28. Chadefaux, B, Coude, M, Hamet, M, et al. Rapid determination of total homocysteine in plasma. Clin Chem, 35, 1989, 2002.
29. May, RC, Hara, Y, Kelly, RA, Branched-chain aminoacid metabolism in rat muscle: Abnormal regulation in acidosis. Am J Physiol 252 (1987), E712–E718.
30. Hara, Y, May, RC, Kelly, RA, et al. Acidosis not azotemia stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 32 (1987), 808–814.
31. Deferrari, G, Garibotto, G, Robauso, C, et al. Splanchnic exchange of aminoacids after aminoacid ingestion in patients with chronic renal insufficiency. Am J Clin Nutr 48 (1988), 72–83.
32. Young, GA, Parsons, FM, Impairment of phenylalanine hydroxlation in chronic renal insufficiency. Clin Sci Mol Med 45 (1973), 89–97.
33. Letteri, JM, Scipione, RA, Phenylalanine metabolism in chronic renal failure. Nephron 13 (1974), 365–371.
34. Tizianello, A, Defrrari, G, Garibotto, G, et al. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 65 (1980), 1162–1173.